Status:
COMPLETED
A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media
Lead Sponsor:
Replidyne
Conditions:
Otitis Media
Eligibility:
All Genders
6-7 years
Phase:
PHASE2
Brief Summary
The study will be conducted in infants and children with acute otitis media, 6 months to less than 7 years old, in Costa Rica and Israel. The primary objective of this trial will be to describe bacter...
Detailed Description
The study will be conducted in infants and children with acute otitis media, 6 months to \<7 years old, in Costa Rica and Israel. Faropenem is to be used as therapy for both simple and complicated AOM...
Eligibility Criteria
Inclusion
- Acute Otis Media
Exclusion
- Any antibiotic for more than 24 hours (unless a treatment failure) within 7 days prior to enrollment
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
328 Patients enrolled
Trial Details
Trial ID
NCT00276042
Start Date
January 1 2006
Last Update
February 8 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
San José, Costa Rica
2
Local Institution
Beersheba, Israel